RIGEL PHARMACEUTICALS INC.
Biotechnology company focused on novel small molecule drugs for rare diseases
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Report 4th Quarter 2020
|
ARNOLD & PORTER KAYE SCHOLER LLP | $10,000 reported |
|
Registration 4th Quarter 2020
|
ARNOLD & PORTER KAYE SCHOLER LLP | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| ARNOLD & PORTER KAYE SCHOLER LLP | 11 | $30,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 5 |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.